100.940 articles found

Prevalence and Associations of Abnormal Levels of Vitamin B6 in People with Parkinson's Disease

Lizarraga K, Wang L, Mesmer H, Shah N, Barbosa W, Logigian E, McDermott M, Lang A.

Movement disorders clinical practice · 2026-10-14

Unveiling the mysteries: neuroprotective potential of <i>Mucuna monosperma</i> seeds in combating haloperidol induced Parkinsonism.

Bhong P, Ingale S, Jadhav P.

J Complement Integr Med · 2026-10-14

DOI: 10.1515/jcim-2026-0188PMID: 42865255

Vitamin B6 Deficiency and Status Epilepticus: A Preventable Cause of Death in People with Parkinson's Disease.

Lizarraga KJ, Kanner AM, Lang AE.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70580PMID: 42872523

Prevalence and Associations of Abnormal Levels of Vitamin B6 in People with Parkinson's Disease.

Lizarraga KJ, Wang L, Mesmer H, Shah N, Barbosa W, Logigian E, McDermott MP, Lang AE.

Mov Disord Clin Pract · 2026-10-14

DOI: 10.1002/mdc3.70865PMID: 42872538

Bladder dysfunction in parkinson's disease: An updated review and guide for the urologist.

McNicholas DP, Vuthiwong J, Gani J.

Ir J Med Sci · 2026-10-14

DOI: 10.1007/s11845-026-04673-9PMID: 42873472

Deficiency of synaptotagmin 9 in the hippocampal region induces synaptic damage and cognitive impairment in Parkinson's disease mice via BDNF/TrkB signaling.

Xu N, Du C, Li Y, Yang W, Li W, Perez RG, Yu S, Lou H.

Neuropharmacology · 2026-10-14

DOI: 10.1016/j.neuropharm.2026.111227PMID: 42874995

Parkinson's disease, Gaucher disease, and bistability in the lysosomal degradation pathway.

Reed MC, Best J, Lansbury P, Justman C, Nijhout HF.

Math Biosci · 2026-10-14

DOI: 10.1016/j.mbs.2026.109827PMID: 42874993

Severe Parkinson's Disease Linked to SNCA Locus Triplication Is Associated with Expression Changes in Platelets: A Case Report.

Jiménez-Román S, Adamuz D, Mena J, Tuset A, Mallo M, Menendez A, Samaniego D, Ispierto L, Vilas D, Pastor P, Beyer K.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70529PMID: 42876074

GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

Tay YW, Lee AL, Schee JP, Lin CH, Tan EK, Shin JH, Chen PS, Fan SP, Li CH, Ng EYL, Kim HJ, Jeon B, Koks S, Vu HTT, Mok KY, Lim YT, Kamaruddin MS, Toh TS, Ding HX, Anuar ANK, Ramli N, Keller Sarmiento IJ, Periñan MT, Fang ZH, Lange LM, Kumar KR, Bardien S, Trinh J, Valente EM, SG10K_Health Consortium, the Global Parkinson's Genetics Program (GP2), Heutink P, Lohmann K, Klein C, Mencacci NE, Lim SY, Ahmad-Annuar A, Tan AH.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70530PMID: 42876073

Elevated erythrocyte membrane pS42-α-synuclein in Parkinson's disease and its changes following plasma cross-incubation.

Zhang Z, Xu J, Huang J, Wang S, Jian M, Feng C, Cui X, Zhou X, Yan J, Xu Y.

Parkinsonism Relat Disord · 2026-10-14

DOI: 10.1016/j.parkreldis.2026.109020PMID: 42887361

Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.

Otmanine K, Hammoudi M, Bendriss H, Feraoun B, Mekhane S, Gherioune N, Benmehache C, Kerrouzi I, Ayadi K, El Miloudi K, Benghalia MA, Otmanine MK, Hentabli M.

Bioorg Chem · 2026-10-14

DOI: 10.1016/j.bioorg.2026.110653PMID: 42893649

MRI-based machine learning models for differentiating Parkinson’s disease and Progressive Supranuclear Palsy

Khruomo VV, - P, Kadavigere R, Nayak K, Sampathila N, Pendem S, Pires T.

· 2026-10-13

DOI: 10.12688/f1000research.190609.1